SMYD2A antibody (Middle Region)
-
- Target See all SMYD2A Antibodies
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
-
Binding Specificity
- Middle Region
-
Reactivity
- Human, Mouse, Rat, Cow, Dog, Horse, Rabbit, Guinea Pig, Pig, Zebrafish (Danio rerio)
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This SMYD2A antibody is un-conjugated
-
Application
- Western Blotting (WB), Chromatin Immunoprecipitation (ChIP)
- Sequence
- SMWLKLGRLY MGLEHKAAGE KALKKAIAIM EVAHGKDHPY ISEIKQEIES
- Predicted Reactivity
- Cow: 100%, Dog: 100%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 86%
- Characteristics
- This is a rabbit polyclonal antibody against SMYD2. It was validated on Western Blot using a cell lysate as a positive control.
- Purification
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human SMYD2
- Top Product
- Discover our top product SMYD2A Primary Antibody
-
-
- Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
- Comment
-
Antigen size: 433 AA
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004." in: Neuro-oncology, Vol. 10, Issue 4, pp. 560-8, (2008) (PubMed).
: "
-
Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004." in: Neuro-oncology, Vol. 10, Issue 4, pp. 560-8, (2008) (PubMed).
-
- Target
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
- Alternative Name
- SMYD2 (SMYD2A Products)
- Synonyms
- HSKM-B antibody, KMT3C antibody, ZMYND14 antibody, 1110020E07Rik antibody, 4930402C15 antibody, Zmynd14 antibody, smyd2-a antibody, im:7146196 antibody, smyd2 antibody, wu:fc02f02 antibody, zgc:110553 antibody, si:dkey-121j17.3 antibody, zgc:136609 antibody, SET and MYND domain containing 2 antibody, SET and MYND domain containing 2 S homeolog antibody, SET and MYND domain containing 2a antibody, SET and MYND domain containing 2b antibody, SMYD2 antibody, Smyd2 antibody, smyd2.S antibody, smyd2a antibody, smyd2b antibody
- Background
-
The specific function of this protein remains unknown.SET domain-containing proteins, such as SMYD2, catalyze lysine methylation (Brown et al., 2006 [PubMed 16805913]).[supplied by OMIM].
Alias Symbols: HSKM-B, KMT3C, MGC119305, ZMYND14
Protein Interaction Partner: UBC, HIST2H3C, HSP90AA1, RB1, EPB41L3, TP53, CLASP2, AKAP11, CDC37, IGF2BP1, AXIN1, GSK3B,
Protein Size: 433 - Molecular Weight
- 50 kDa
- Gene ID
- 56950
- NCBI Accession
- NM_020197, NP_064582
- UniProt
- Q9NRG4
-